pharmaceutical industry

KALAMAZOO, MI -- Zoetis Inc., an international animal-health drugmaker, which employs about 1,000 people at its research and development headquarters in Kalamazoo, will cut up to 25 percent of its total workforce. (Kalamazoo Gazette)

Refusing to take “no” for an answer, Mylan N.V. today raised its offer to acquire Perrigo Co. plc to nearly $32.7 billion— an offer that was quickly rejected. The unsolicited offer made this morning is the third the Potters Field, England-based Mylan has made for Perrigo. The company offered $75 in cash and 2.3 share of Mylan stock for every Perrigo share and the value is based on Mylan’s April 8 closing share price of $68.36. (MiBiz)

ALLEGAN, MI – Perrigo Co. announced Tuesday it has rejected generic drugmaker Mylan NV's unsolicited buyout for $28.9 billion. In early April, Mylan offered $205 a share in cash and stock, but on Tuesday, the Perrigo board of directors announced it had unanimously rejected the offer, saying Mylan had "substantially undervalued" the company as well as its future growth prospects. (Kalamazoo Gazette)

Company headquarters are now based in Ireland

Deal is to be completed in the first quarter of 2015